United Therapeutics Corporation UTHR
559.10 USD -18.24 (-3.16%)
Regular-session close
551.03 -8.08 -1.44%
Pre-market · Nov 20, 5:37 AM ET
554.48 Day range 578.80
455.63 52-week range 614.23
- YTD
- +14.75%
- 1 year
- +17.77%
Held by funds
335 US ETFs and mutual funds hold UTHR · largest positions
- IJH 0.74% of fund $919.25M
- NJH 0.71% of fund $830.21M
- VTI 0.03% of fund $738.30M
- VB 0.29% of fund $523.15M
- VGHCX 1.36% of fund $519.41M
- VXF 0.28% of fund $261.63M
- AFTY 4.05% of fund $231.01M
- MDY 0.74% of fund $190.70M
- IBB 1.70% of fund $187.47M
- XBI 1.75% of fund $182.38M
- XMHQ 3.06% of fund $177.39M
- VBR 0.26% of fund $170.24M
- XMMO 2.65% of fund $169.94M
- IJK 1.49% of fund $157.09M
- NNK 1.36% of fund $148.80M
- VFLO 1.15% of fund $147.60M
- VBK 0.33% of fund $145.44M
- SPMD 0.74% of fund $140.07M
- VETS 6.96% of fund $136.55M
- VWUSX 0.28% of fund $124.93M
Ownership
Held by insiders 2.06%
Held by institutions 105.49%
Float held by institutions 107.71%
Institutions 1,186
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.09% | 5,575,162 | 3.12B | Sep 29, 2026 |
| Avoro Capital Advisors LLC | 6.47% | 2,755,555 | 1.54B | Sep 29, 2026 |
| State Street Corporation | 4.58% | 1,952,557 | 1.09B | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.53% | 1,928,928 | 1.08B | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.49% | 1,911,530 | 1.07B | Sep 29, 2026 |
| Wellington Management Group, LLP | 4.46% | 1,899,605 | 1.06B | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.59% | 1,527,799 | 854.19M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 1,347,720 | 753.51M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 973,490 | 544.28M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.69% | 719,385 | 402.21M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.14% | 486,555 | 272.03M | Jun 29, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.76% | 323,432 | 180.83M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENKOWITZ MICHAEL | President | Conversion of Exercise of derivative security | Mar 12, 2026 | 0 |
| CAUSEY CHRISTOPHER | Director | Sale | Mar 29, 2026 | 4,190 |
| EDGEMOND JAMES C. | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 21, 2026 | 18,876 |
| GILTNER RICHARD A | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 21,884 |
| KURZWEIL RAYMOND C | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 13,320 |
| MAHON PAUL A | General Counsel | Sale | Nov 4, 2026 | 45,172 |
